We observed increased DNA methylation in EGFR, ERBB2, ERBB3, FGFR3, and PDGFRB in IDH-mutant gliomas as the mean methylation of each gene was statistically greater than that of IDH-wildtype (Figure 2A; Figure S2A). This evidence concerns the gene ERBB3 and central nervous system cancer.